Inhalation techniques in the treatment of asthma;Técnicas de inhalación en el tratamiento del asma

Anales del Sistema Sanitario de Navarra

Volumn 26, Issue SUPPL. 2, 2003, Pages 139-146

  Rodríguez Biempica, Marisa ^a,b   Celay, E ^a   Larrea, I ^a   Urdanoz M ^a   Zabalegui, A ^a   Ollo, B ^a  

^a Instituto de Investigación Sanitaria de Navarra   (Spain)

^b Seccion de Alergologia   (Spain)

Author keywords

Health education; Inhalation techniques; Inhalers

Indexed keywords

AEROSOL; APNEA; ASTHMA; DEVICE; DRUG EFFECT; ERROR; HUMAN; INHALATION; INHALER; METERED DOSE INHALER; OUTCOMES RESEARCH; PATIENT EDUCATION; REVIEW; TECHNIQUE;

ADMINISTRATION, INHALATION; ASTHMA; EQUIPMENT DESIGN; HUMANS; NEBULIZERS AND VAPORIZERS; PATIENT EDUCATION;

EID: 0042819795     PISSN: 11376627     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (18)

1. NABERÁN KX, CALVO E, GARCIA L, HERNÁNDEZ MF et al. Factores de riesgo. Manejo del asma en Atención Primaria. Recomendaciones SemFYC. Edide, Barcelona 1996; 13-18.
2. CAFFARELLI C, CAVAGNI G, GIORDANO S, TERZI V, PERRONE F. Reduced pulmonary function in multiple food-induced, exercise-related episodies of anaphylaxis. J Allergy Clin Immunol 1996; 98: 762-765.
3. PAULS JD, CROSS D. Food-dependent exercise-induced anaphylaxis to corn. J Allergy Clin Immunol 1998; 101: 853-854.
4. OWENS-HARRINSON G, GRIMM R, GRAY D, HARRISON O. Evaluation of education by a pharmacist to hospitalized patients who use metered-dose inhalers. Hosp Pharm 1996; 31: 677-681.
5. DETULLIO PL, CORSON ME. Effect of pharmacist counseling on ambulatory use of aerosolized. Am J Hosp Pharm 1987; 44: 1802-1806.
6. REBUCK D, DZYNGEL B, KHAN K, KESTEN RN, CHAPMAN KR. The effect of structured versus conventional inhaler education in medical housestaff. J Asthma 1996; 33: 385-393.
7. United Nations Environment Programme. Report of the technology and economic assessment panel: Montreal protocol on substances that deplete the ozone layer. Nairobi, Kenia: United Nations environment Programme, Ozone Secretariat, 1995; 89-99.
8. FISHER DA, HALES CH, WANG WC et al. Model calculations of the relative effects of CFCs and their replacements on global warning. Nature 1990; 344: 513-516.
9. Guidelines for the diagnosis and management of asthma. Expert panel report 2. NIH 1997.
10. BARLEY C. Inhalation devices and aerosol therapy. On Continuing Practice 1989; 16: 30-39.
11. CLARK DJ, LIPWORTH BJ. Effect of multiple actuations, delayed inhalation and antistatic treatment on the lung biovailability of salbutamol via a spacer device. Thorax 1996; 51: 981-984.
12. BARRY PW, O'CALLAGHAN C. Multiple actuations of salbutamol MDI into a spacer device reduce the amount of grug recovered in the respirable range. Eur Respir J 1994; 7: 1707-1709.
13. O'DONOHUE WJ, CHAIR FCCP. National Association for Medical Direction of Respiratory Care. Consensus Group. Guidelines for the use of nebulizers in the home and at domiciliary sites. Report of a consensus conference. Chest 1996; 109: 814-820.
14. MANDELBERG A, CHEN E, NOVISKI N, PRIEL IE. Nebulized wet aerosol treatment in emergency department-is it essential? Comparison with spacer device for metered-dose inhaler. Chest 1997; 112: 1501-1505.
15. BARRY PW, O'CALLAGHAN C. Inhalational drug delivery from seven different spacer devices. Thorax 1996; 51: 835-840.
16. PLAZA V, CASAN P, DE DIEGO A, DUCE F, GALDIZ YB, LÓPEZ-VINA A et al. Recomendaciones para la utilización de fármacos inhalados. Arch Bronconeumol 1996; 32: 8-9.
17. BURNELL PKP, SMALL T, DOIG S, JOHAL B, JENKINS R, GIBSON GJ et al. Exvivo product performance of Diskus™ and Turbuhaler™ inhalers using inhalation profiles from patients with severe chronic obstructive pulmonary disease. Respir Med 2001; 95: 324-330.
18. HILL LS. Inhaler selection in asthma: choosing the right device. Horizons January 1993; 29-32.